Appropriately aggregate holistic technologies via accurate expertise. Intrinsicly strategize worldwide initiatives and premium methodologies.
CMV serostatus is associated with improved survival and delayed toxicity onset following anti-PD-1 checkpoint blockade
Milotay G. et al, (2025), Nature Medicine
Priorities for rapid and cost-effective vaccines to improve outbreak responses
Gilbert SC., (2025), PLOS Biology, 23, e3003114 - e3003114
Genetically distinct within-host subpopulations of hepatitis C virus persist after Direct-Acting Antiviral treatment failure
Zhao L. et al, (2025), PLOS Pathogens, 21, e1012959 - e1012959
Risk analysis for outpatient experimental infection as a pathway for affordable RSV vaccine development.
Siegal EZ. et al, (2025), NPJ vaccines, 10
Workshop report: One Health challenges and knowledge gaps in the control of intracellular infections with a focus on tuberculosis and leishmaniasis
Miller M. et al, (2025), Vaccine, 53, 126929 - 126929
Quantifying potential immortal time bias in observational studies in acute severe infection
Yates TA. et al, (2025), Open Forum Infectious Diseases
Nanopore adaptive sampling for bacterial identification from periprosthetic joint replacement tissue
Street TL. et al, (2025)
Complement-mediated enhancement of SARS-CoV-2 antibody neutralisation potency in vaccinated individuals.
Mellors J. et al, (2025), Nature communications, 16
Genetic association studies in critically ill patients: a systematic review.
Zhang W. et al, (2025), EBioMedicine, 114
Production of an immunogenic trivalent poliovirus virus-like particle vaccine candidate in yeast using controlled fermentation.
Sherry L. et al, (2025), NPJ vaccines, 10
Low-Dose Yellow Fever Vaccine in Adults in Africa
Kimathi D. et al, (2025), New England Journal of Medicine, 392, 788 - 797
Pneumococcal Carriage and Disease in Adults in England, 2011–2019: The Importance of Adults as a Reservoir for Pneumococcus in Communities
El Safadi D. et al, (2025), The Journal of Infectious Diseases, 231, e17 - e27
A 5-transcript signature for discriminating viral and bacterial etiology in pediatric pneumonia
Viz-Lasheras S. et al, (2025), iScience, 28, 111747 - 111747
Acceptability of the R21/Matrix-M malaria vaccine alongside existing malaria interventions in the trial context.
Diawara H. et al, (2025), BMJ global health, 10
Incidence of diabetes mellitus following hospitalisation for COVID‐19 in the United Kingdom: A prospective observational study
Tyrer F. et al, (2025), Diabetes, Obesity and Metabolism, 27, 767 - 776
MAIT cells protect against sterile lung injury
Zhang X. et al, (2025), Cell Reports, 44, 115275 - 115275